GSA Capital Partners »

Stoke Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $537k 102k 5.26
2023-09-30 $1.4M 348k 3.94
2023-06-30 $602k 57k 10.63
2023-03-31 $336k 40k 8.32
2022-12-31 $661k 72k 9.24
2022-09-30 $965k 75k 12.84
2022-03-31 $852k 41k 21.04
2021-12-31 $587k 25k 23.99
2021-09-30 $248k 9.8k 25.43